ISSN: 2155-9570
David Johnson
Posters-Accepted Abstracts: J Clin Exp Ophthalmol
Epithelial ingrowth is a complication following laser assisted in-situ keratomileusis (LASIK) in which epithelial cells gain access and proliferate in the lamellar interface. Patients with epithelial ingrowth will typically present with decreased best-corrected visual acuity, foreign body sensation, and a worsening of dry eye symptoms due to epithelial irregularities. However, patients may be asymptomatic in the initial phase. The most common treatment option involves lifting the flap and mechanically debriding the epithelial cells from the stromal bed and undersurface of the flap. Recurrence is common if poor flap adherence or flap misalignment is present. There are alternative therapies such as alcohol debridement, suturing, fibrin tissue adhesive, and phototherapeutic keratectomy (PTK) if the initial treatment is unsuccessful. Progressive epithelial ingrowth left untreated can result in loss of best-corrected visual acuity secondary to irregular astigmatism, or flap necrosis requiring complete flap removal.